ISSN: 2167-8421

Journal Home

Journal Guideline

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Q1 Unclaimed

Informa Healthcare United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is a journal indexed in SJR in Medicine (miscellaneous) and Neurology (clinical) with an H index of 85. It has an SJR impact factor of 1,066 and it has a best quartile of Q1. It has an SJR impact factor of 1,066.

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration focuses its scope in these topics and keywords: amyotrophic, lateral, sclerosis, systematic, methods, latestage, originclinical, patients, sclerosismotor, plasma, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Neurology (Q1) Neurology (clinical) (Q1) Neurology (clinical) (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

1,066

SJR Impact factor

85

H Index

109

Total Docs (Last Year)

291

Total Docs (3 years)

3806

Total Refs

773

Total Cites (3 years)

277

Citable Docs (3 years)

2.38

Cites/Doc (2 years)

34.92

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Occupational exposure to magnetic fields and electric shocks and risk of ALS: The Swiss National Cohort

Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population

When more is needed: The utility of the frontotemporal dementia scale in ALS

Experience of complementary and alternative medicine in patients with amyotrophic lateral sclerosis and their families: A qualitative study

Cortical contributions to the flail leg syndrome: Pathophysiological insights

Rapidly progressive frontotemporal dementia and bulbar amyotrophic lateral sclerosis in Portuguese patients with C9orf72 mutation

Twelve-month duration as an appropriate criterion for flail arm syndrome

Respiratory measurements and airway clearance device prescription over one year in amyotrophic lateral sclerosis

Width of 3rd ventricle determined by brain stem sonography does not distinguish bulbar motor syndromes

Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: A new focus of ALS associated with Parkinsonism

Amyotrophic lateral sclerosis mimic syndrome due to neurosyphilis

Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures

SHOW MORE ARTICLES

Coeliac disease mimicking Amyotrophic Lateral Sclerosis

Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis

State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model

Record linkage between hospital discharges and mortality registries for motor neuron disease case ascertainment for the Spanish National Rare Diseases Registry

Detection of a novel frameshift mutation and regions with homozygosis within ARHGEF28 gene in familial amyotrophic lateral sclerosis

Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly

NP001 regulation of macrophage activation markers in ALS: A phase I clinical and biomarker study

A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosis

Equivalency and practice effects of alternative versions of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS)

Gait in amyotrophic lateral sclerosis: Is gait pattern differently affected in spinal and bulbar onset of the disease during dual task walking?

The rise of innovative clinical trial designs: what's in it for amyotrophic lateral sclerosis?

Reliability and validity of speech & pause measures during passage reading in ALS